HIV treatment makes patients MORE susceptible to syphilis


  • The drug treatment HAART might be increasing the risk of contracting syphilis
  • HAART treats HIV and prevents the progression of the infection to AIDS
  • Researchers say the high risk is a mix of behavioral and immune changes
  • HAART may also hinder the body’s clearance of T. pallidum which causes syphilis

Mary Kekatos For Dailymail.com

View
comments

Drug treatments to suppress HIV could be driving up rates of syphilis by eliminating the ‘fear factor’, a new study has warned.

Highly active antiretroviral therapy (HAART) can control viral load – making it virtually undetectable – and preventing or delaying the progression to AIDS. 

However, a new report claims the absence of the fear factor may have prompted higher rates of sexually-transmitted diseases (STDs) as a result of risky, unprotected sex.

This, they say, could be an explanation for the rapidly rising rates of syphilis in gay and bisexual men in the last three years.

A pharmacist pours Truvada pills – a daily antiretroviral reducing the risk of contracting HIV – back into a bottle. A new study suggests antiretroviral therapy may increase the risk of contracting syphilis in gay/bisexual men 

Reported cases of syphilis in the US rose by 15 percent from 2013 to 2014 and another 19 percent from 2014 to 2015, according to the Centers for Disease Control and Prevention.

Among gay/bisexual men, syphilis rates are 107 times higher than among straight men. In 2015, 81.7 percent of the reported male syphilis cases were from men whom had had sex with other men.

But researchers say it’s not clear why rates of syphilis among gay/bisexual men are much higher than chlamydia or gonorrhea rates.

This is because HAART boosts immune system activity, and therefore is expected to lower susceptibility to infection.

HOW TO SPOT SYPHILIS

Syphilis is a chronic bacterial disease that can be contracted by other means but is typically a sexually-transmitted disease.

In very rare cases, it can be spread through prolonged kissing, as well as the more common routes of transmission: vaginal, anal and oral sex. 

It comes from the bacteria Treponema pallidum.

Signs and symptoms:

Sufferers develop sores, though these can often go ignored. 

The infection develops in stages. 

Stage one

  • Small, painless sores (like ulcers) on genitals or in the mouth 
  • Appear within 10-90 days after exposure 
  • They disappear within six weeks, and do not leave a scar, before developing to stage two 

Stage two

  • Rosy rash on the palms of the hand and soles of the feet 
  • Moist warts in the groin White patches inside the mouth 
  • Swollen glands 
  • Fever 
  • Weight loss 
  • This all fades away without treatment before developing into stage three

Latent syphilis

  • Dormant, no symptoms 

Stage three

  • Without treatment it can progress to more severe issues with the heart, brain and nerves 
  • Paralysis 
  • Blindness 
  • Dementia 
  • Deafness 
  • Impotence 
  • Death

Treatment: 

In the early stages, patients can receive an injection of Benzathine penicillin G. This will not undo the internal damage but will eliminate the infection. 

For those with latent syphilis – and are unsure how long they had it – doctors recommend having three doses of the penicillin injection, seven days apart from each other. 

In the study, scientists reviewed the impact of HAART on behavioral and immune system changes.

Researchers created two risk ‘models’ to test the likelihood of syphilis infection.

The lower risk model compared someone on HAART with no treatment in an HIV-positive partner, and the higher risk model compared existing syphilis infection with a non-infected partner who was either HIV-negative or positive.

Behavior change was taken to mean that HAART would result in more sexual partners.

Immune system changes were taken to mean that HAART would boost susceptibility to T. pallidum – the bacteria that causes syphilis.

Results showed that either factor could produce outbreaks of syphilis that would be substantially higher than expected, but the factors together produced a greater number of infection than individually – similar to figures seen in the current outbreak.

Researchers say this suggests that there’s an exchange between behavioral change and immune system changes.

Additionally, the body’s clearance of T. pallidum relies on an increase in the number of an immune system cell called a T cell and a flow of chemicals that stimulate an inflammatory response. HAART dampens down these activities.

Clearance of chlamydia and gonorrhea is less reliant on these processes, say the researchers. 

Drs Susan Tuddenham, Maunank Shah, and Khalil Ghanem from Johns Hopkins University School of Medicine, Baltimore, in an editorial, cautioned that the rise in syphilis cases may simply reflect inadequate screening for chlamydia and gonorrhea.

They also pointed to previous outbreaks of syphilis in straight men and women in the 1980s and 1990s before the advent of HAART.

Similarly, the professors suggested the researcher’s calculations didn’t take into account of the complexities of sexual relationships.

This included relationship length or the number of concurrent partners, or decreased use of condoms in long term relationship – all of which might influence infection risk. 

The doctors wrote: ‘We are living in an era where [antiretroviral therapy] is being used to effectively treat and prevent HIV infection. 

‘To some extent this seems to have tempered the urgency to control other STDs. As history has shown many times over, that would be a costly mistake.’

They added: ‘If further investigations support a role for [antiretroviral therapy] in increasing susceptibility to syphilis, this will provide one more reason why screening, diagnosis and treatment of STDs in [men who have sex with men] must be prioritized.’ 

Comments (0)

Share what you think

No comments have so far been submitted. Why not be the first to send us your thoughts,
or debate this issue live on our message boards.

Find out now